Orphazyme announces presentation of 2020 Annual Report
Copenhagen, Denmark and Chicago, IL, USA, February 23, 2021 – Orphazyme A/S (ORPHA.CO; ORPH) (“the Company”), a late-stage biopharmaceutical company pioneering the Heat-Shock Protein response for the treatment of neurodegenerative rare diseases, today announced that the Company will be hosting an investor call during which the Orphazyme management team will be presenting the Company’s 2020 Annual Report. The presentation will be followed by a Q&A session.
The call will be held on Tuesday, March 2, 2021 at 2.00 PM CET.
Event Title: Orphazyme Annual Report 2020
The presentation will also be available via webcast: https://edge.media-server.com/mmc/p/kmp575pf
After the call, the presentation will be available via the above link.
For additional information, please contact
Anders Vadsholt, CFO +45 28 98 90 55
About Orphazyme A/S
Networking LIVE! Reception - On the Amazing Spacious Seaside Patio of the Loews Miami Beach Resort
Keynote Presentation TBA
IoT Evolution #TECHSUPERSHOW Expo Hall Open